Gronowski, A.M., Powers, M., Stenman, U.H., Ashby, L. and Scott, M.G. (2009) False-Negative Results from Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Caused by Excess hCGbeta Core Fragment Vary with Device Lot Number. Clinical Chemistry, 55, 1885-1886.
http://dx.doi.org/10.1373/clinchem.2009.133280

has been cited by the following article:

• TITLE: Evaluation of a Plasma hCG Method for Point of Care Testing with the Aim of Shortening Test-Turnaround-Times

  AUTHORS: Anna-Karin Wikström, Magnus Hagmar, Göran Ronquist, Anders Larsson

  KEYWORDS: Human Chorionic Gonadotropin, Pregnancy, Method Evaluation, Point of Care Test

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.5 No.6, June 19, 2015

  ABSTRACT: Objective: To examine the correlation between plasma hCG results obtained with the new i-STAT® hCG point of care test with those concomitantly obtained from the central hospital laboratory utilizing the same patient samples. Methods: Prospective cross-sectional laboratory test evaluation. We compared plasma hCG results obtained with the i-STAT® hCG test (Abbott Point of Care, Princeton, NJ, USA) with Architect Ci8200 (Abbott Laboratories, Abbott Park, IL, USA). We also calculated the total coefficient of variation (CV) for the i-STAT® method. Results: The two methods showed a good linear correlation (R2 = 0.994; slope 1.03) and CV for the i-STAT® method was 2.1% - 5.2%. Conclusion: We suggest that the i-STAT® hCG blood assay could be used as a complement to urine hCG assays in clinical situations when rapid test results are needed and urine is not available.